Paris-based SMS verification technology company Prelude has secured $8 million in seed funding led by Singular and Seedcamp. The company, founded in 2022 by Matias Berny and Quentin Le Bras, develops ...
In a report released today, Peter Lawson from Barclays maintained a Sell rating on Prelude Therapeutics (PRLD – Research Report), with a price target of $1.00. The company’s shares closed yesterday at ...
Dominick Brown, Cyrie Topete, and Aaron Choate perform “Sweet Gwen Suite” in Hubbard Street Dance Company’s fall series dress rehearsal at Steppenwolf Theatre in Chicago on Nov. 15, 2024. (Tess ...
Prelude Therapeutics Inc (NASDAQ:PRLD), a clinical-stage biopharmaceutical company focused on developing precision oncology therapies, finds itself at a critical juncture as it approaches several key ...